Market Overview
Medical oxygen concentrators are electro-medical devices that extract oxygen from surrounding air, filter it, and deliver concentrated oxygen to patients requiring respiratory support. The market includes stationary concentrators for home or clinical use and portable oxygen concentrators designed for mobility, with the global market valued at approximately $3.29 billion in 2025. Product technology continues to advance toward lighter weight, higher flow rates, and improved battery life for portable units.
- •Market valued at $3.29 billion in 2025, projected to reach approximately $5.2 billion by 2031 based on 6.18% CAGR
- •Stationary concentrators dominate volume for home healthcare, while portable segment grows faster due to mobility demand
- •Applications span COPD management, asthma, sleep apnea, and post-COVID respiratory rehabilitation
Growth Drivers
The rising global prevalence of chronic respiratory diseases, particularly chronic obstructive pulmonary disease affecting over 200 million people worldwide, creates sustained demand for long-term oxygen therapy solutions. Aging populations in developed and emerging economies increase the patient pool requiring home-based oxygen therapy as elderly populations prefer aging-in-place over institutional care. Expanding healthcare infrastructure in Asia-Pacific and Latin America, combined with insurance coverage expansion, improves patient access to prescribed oxygen concentrators.
- •Over 65 million people globally suffer from moderate-to-severe COPD requiring long-term oxygen therapy
- •Technological improvements reducing device weight and power consumption expand portable concentrator usability
- •COVID-19 pandemic accelerated home oxygen therapy adoption and normalized concentrator use beyond traditional clinical settings
Segmentation and Regional Analysis
The market divides into portable oxygen concentrators and stationary oxygen concentrators, with stationary units holding the larger revenue share due to higher unit prices and home healthcare demand. Portable concentrators represent the faster-growing segment as manufacturers develop lighter, pulse-dose and continuous-flow capable devices for active patients. Geographically, North America leads the market due to high COPD prevalence, favorable reimbursement policies, and advanced home healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region driven by large patient populations and improving medical access.
- •North America accounts for the largest regional share, followed by Europe and Asia-Pacific
- •Home healthcare end-users represent the dominant application segment, outpacing hospitals and clinics
- •Portable oxygen concentrator segment expected to grow at above-market rate due to demand for patient mobility
Trends and Outlook
What are the recent trends and outlook?
Integration of smart connectivity features enabling remote patient monitoring and telehealth compatibility represents an emerging trend as healthcare systems prioritize home-based care management. Manufacturers are developing concentrators compatible with mobile apps for tracking oxygen usage, battery status, and alerting caregivers or providers to device issues. The market outlook remains positive through 2034, with continued expansion in emerging markets and ongoing product innovation expected to sustain growth above the projected 6% annual rate.
- •Smart oxygen concentrators with Bluetooth and cellular connectivity enabling remote monitoring gaining market traction
- •Lightweight, travel-friendly designs expanding use cases beyond home to outdoor activities and commercial aviation
- •Long-term forecast projects market approaching $5.2 billion by 2031 and continuing growth trajectory through 2034
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.